How Many Physicians Have Opted Out of the Medicare Program?

Image
peter doshi :: Article Creator New Research Reports On Financial Entanglements Between FDA Chiefs And The Drug Industry An investigation published by The BMJ today raises concerns about financial entanglements between US Food and Drug Administration (FDA) chiefs and the drug and medical device companies they are responsible for regulating. Regulations prohibit FDA employees from holding financial interests in any FDA "significantly regulated organization" and the FDA says it takes conflicts of interest seriously, but Peter Doshi, senior editor at The BMJ, finds that financial interests with the drug industry are common among its leaders. Doshi reports that nine of the FDA's past 10 commissioners went on to work for the drug industry or serve on the board of directors of a drug company. That includes Margaret Hamburg, who led FDA between 2009 and 2015, but whose story is less well known. Like her colleagues, Margaret Hamburg h

RSV: FDA to decide on Pfizer vaccine for older adults by May 2023 - CNBC

In this article

  • PFE
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.
John Thys | AFP | Getty Images

The Food and Drug Administration is expected to decide by spring whether to approve Pfizer's vaccine to prevent respiratory syncytial virus, or RSV, in adults ages 60 and older.

Pfizer, in a statement Wednesday, said the FDA has accepted its RSV vaccine candidate for review under an expedited process that reduces the approval timeline by four months. The FDA is expected to make a final decision on whether to approve the vaccine by May 2023.

RSV is a common respiratory virus that causes cold-like symptoms in most people, but it can result in severe illness in infants and older adults. Between 60,000 and 120,000 older adults are hospitalized with RSV every year and 6,000 to 10,000 older adults die from the virus.

There is no vaccine for RSV.

Pfizer's vaccine candidate was about 86% effective in preventing severe lower respiratory tract illness, defined as three or more symptoms. The vaccine was about 67% effective at preventing milder lower respiratory tract illness, defined as two or more symptoms.

"With no RSV vaccines currently available, older adults remain at-risk for RSV disease and potential severe outcomes, including serious respiratory symptoms, hospitalization, and in some cases, even death," said Annaliesa Anderson, Pfizer's head of vaccine research and development.

The U.S. is facing an unusually tough RSV season this year. RSV transmission was very low during the Covid pandemic due to masking and social distancing measures. Many people did not get infected as a consequence, so population immunity is lower right now.

Since October, seniors have been hospitalized with RSV at 10 times the rate observed in 2018 to 2019, the last full season before the onset of the Covid pandemic.

Pfizer is also developing a maternal vaccine to protect newborns who are too young for vaccination.

CNBC Health & Science

Read CNBC's latest global health coverage:

  • U.S. will require airline passengers traveling from China to test negative for Covid
  • U.S. records 100 million Covid cases but more than 200 million Americans have probably had it
  • Supreme Court extends Trump-era pandemic immigration rule to allow quicker deportations
  • Mask up again, says infectious disease expert: The tripledemic is hitting 'too fast and too furious'
  • Millions at risk of losing Medicaid in the spring under provision tucked inside $1.7 trillion federal spending bill
  • Walgreens and CVS are limiting the sale of kids' medicine
  • Omicron boosters are 84% effective at keeping seniors from being hospitalized with Covid, CDC says
  • Most nursing home residents haven't had omicron booster ahead of expected winter Covid wave
  • Growing obesity crisis in U.S. prompts CDC to expand body mass index charts for severely overweight kids
  • Biden administration makes at-home Covid tests available for free again this winter
  • Omicron BQ, XBB subvariants are a serious threat to boosters and knock out antibody treatments, study finds

Comments

Popular posts from this blog

Observership Program listings for international medical graduates

Vaccination Sites | Covid-19

Vaccination Sites | Covid-19